RT Journal Article SR Electronic T1 Toxoplasma gondii infection and insomnia: a case control seroprevalence study JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2022.03.17.22272569 DO 10.1101/2022.03.17.22272569 A1 Alvarado-Esquivel, Cosme A1 Estrada-Martínez, Sergio A1 Pérez-Álamos, Alma Rosa A1 Ramos-Nevarez, Agar A1 Botello-Calderon, Karina A1 Alvarado-Félix, Ángel Osvaldo A1 Vaquera-Enríquez, Raquel A1 Alvarado-Félix, Gustavo Alexis A1 Sifuentes-Alvarez, Antonio A1 Guido-Arreola, Carlos Alberto A1 Rábago-Sánchez, Elizabeth A1 Saenz-Soto, Leandro YR 2022 UL http://medrxiv.org/content/early/2022/03/18/2022.03.17.22272569.abstract AB Aim To determine the association between Toxoplasma gondii (T. gondii) infection and insomnia.Materials and methods Through an age-and gender-matched case-control study, 577 people with insomnia (cases) and 577 people without insomnia (controls) were tested for anti-T. gondii IgG and IgM antibodies using commercially available enzyme-immunoassays.Results Anti-T. gondii IgG antibodies were found in 71 (12.3%) of 577 individuals with insomnia and in 46 (8.0%) of 577 controls (OR=1.62; 95% CI: 1.09-2.39; P=0.01). Men with insomnia had a higher (16/73: 21.9%) seroprevalence of T. gondii infection than men without insomnia (5/73: 6.8%) (OR: 3.81; 95% CI: 1.31-11.06; P=0.009). The rate of high (>150 IU/ml) anti-T. gondii IgG antibody levels in cases was higher than the one in controls (OR=2.21; 95% CI: 1.13-4.31; P=0.01). Men with insomnia had a higher (8/73: 11.0%) rate of high anti-T. gondii IgG antibody levels than men without insomnia (0/73: 0.0%) (P=0.006). The rate of high anti-T. gondii IgG antibody levels in cases >50 years old (11/180: 6.1%) was higher than that (3/180: 1.7%) in controls of the same age group (OR: 3.84; 95% CI: 1.05-14.00; P=0.05). No difference in the rate of IgM seropositivity between cases and controls was found (OR=1.33; 95% CI: 0.57-3.11; P=0.50).Conclusions Results of this seroepidemiology study suggest that infection with T. gondii is associated with insomnia. Men older than 50 years with T. gondii exposure might be prone to insomnia. Further research to confirm the association between seropositivity and serointensity to T. gondii and insomnia are needed.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialN/A.Clinical Protocols N/A. Funding StatementThis study was financially supported by Secretary of Public Education, Mexico (Grant No. DSA/103.5/14/11311). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethical Committees of the Institute of Security and Social Services for the State Workers and the General Hospital of the Secretary of Health in Durango City, Mexico approved this project. A written informed consent from each participant was obtained.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Not ApplicableAll relevant data are within the manuscript and its supporting information files.N/A.